tradingkey.logo

Becton Dickinson and Co

BDX
查看詳細走勢圖
201.040USD
-0.880-0.44%
收盤 01/29, 16:00美東報價延遲15分鐘
57.38B總市值
34.46本益比TTM

Becton Dickinson and Co

201.040
-0.880-0.44%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.44%

5天

-2.49%

1月

+2.40%

6月

+9.89%

今年開始到現在

+3.59%

1年

-19.29%

查看詳細走勢圖

TradingKey Becton Dickinson and Co股票評分

單位: USD 更新時間: 2026-01-28

操作建議

Becton Dickinson and Co當前公司基本面數據相對健康,最新ESG揭露屬於行業中等水平。增長潛力很大。當前估值合理,在醫療設備與耗材行業排名12/205位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為208.21。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Becton Dickinson and Co評分

相關信息

行業排名
12 / 205
全市場排名
74 / 4540
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Becton Dickinson and Co亮點

亮點風險
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入21.84B美元
高分紅
公司屬於高分紅公司,最新股息支付率71.28%
穩定分紅
公司5年內持續分紅,最新股息支付率71.28%
估值低估
公司最新PE估值34.61,處於3年歷史低位
機構加倉
最新機構持股268.89M股,環比增加0.03%
雷·達裡奧持倉
明星投資者雷·達裡奧持倉,最新持倉9.50K股

分析師目標

基於 14 分析師
買入
評級
208.213
目標均價
+3.18%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Becton Dickinson and Co新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Becton Dickinson and Co簡介

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
公司代碼BDX
公司Becton Dickinson and Co
CEOPolen (Thomas E)
網址https://www.bd.com/
KeyAI